Prompt commencement of intravenous fluid and insulin, appropriate potassium replacement, and timely use of 10% glucose infusion to prevent iatrogenic hypoglycemia, continuation of long-acting insulin during DKA treatment, timely conversion to variable-rate insulin infusion, timely conversion to patient’s usual subcutaneous insulin regimen, and inpatient diabetes nurse review all had improvements in the adherence scores compared to the first audit. The gene discussed is INS; the disease is diabetes mellitus.